RNA Outsourcing Resources

1. Investors Trust Strong Supply Chains 3/2/2026

   Investors now value operational maturity as much as science. Early, intentional supply‑chain planning shows scalability, lowers risk, and builds confidence in reliable growth.

2. Understanding Technology Transfer In Pharmaceutical Contract Manufacturing 10/16/2024

   Technology transfer is a crucial process in the pharmaceutical industry, ensuring drugs developed in labs can be manufactured consistently at scale.

3. Is Not Using A CDMO Slowing Down Your Process Development? 4/27/2020

   Consider what process development capabilities you have versus what you could possibly gain from working with a CDMO to not only be successful but also improve your chances of getting to market sooner.

4. Built Like A Tech Company: Why CROs Need A New Operating System 10/20/2025

   See why building digital, automated infrastructure is essential, and better aligns CROs with today's speed, compliance, and innovation needs.

5. mRNA: How To Build A Custom Program Using CDMO Services 1/4/2023

   Development of RNA-based therapies sits at the cutting edge of vaccine and oncology innovation, in addition to holding promise in dozens of other therapeutic areas.

6. Avoiding The Pitfalls Of LNPs And Complex Formulations

   Explore the necessary components of a smooth tech transfer for LNP-based drugs, including the variables that impact LNP formulation and the outsourcing strategies needed to avoid common pitfalls.

7. Improving Toxicology Testing For Inhalation Products 1/22/2024

   By embracing new approach methods, regulatory agencies can revolutionize toxicology testing. These methods can be adapted for various medications, including inhalers and nasal-administered drugs.

8. Solving Key Gene Therapy Logistics Challenges With Advanced Technology 1/8/2025

   Discover how cutting-edge logistics innovations are redefining gene therapy transportation to ensure safety, efficiency, and sustainability.

9. Phase-Appropriate Approaches To Manufacturing And Testing 3/14/2025

   Accelerate the development of high-quality biopharmaceuticals by implementing phase-appropriate, risk-based manufacturing and testing strategies that ensure timely progression.

10. Unmatched Beginnings For Late-Phase Success 6/2/2026

    Early research choices shape outcomes. Focusing on reproducibility, scalability, regulatory fit, and supply stability early cuts risk, prevents delays, and supports smoother development progress.